Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 64, Number 4, February 22, 2005
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Udd, B.
Right arrow Articles by Hackman, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Udd, B.
Right arrow Articles by Hackman, P.
Related Collections
Right arrow Muscle disease
Right arrow All Genetics
NEUROLOGY 2005;64:636-642
© 2005 American Academy of Neurology

Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J

B. Udd, MD, PhD, A. Vihola, MSc, J. Sarparanta, I. Richard, PhD and P. Hackman, PhD

From the Neurological Department (Dr. Udd, A. Vihola), Vaasa Central Hospital, Department of Neurology (Dr. Udd), Tampere University Hospital, and Folkhälsan Institute of Genetics and Department of Medical Genetics (Dr. Hackman, A. Vihola and J. Sarparanta), University of Helsinki, Finland; and Généthon-CNRS8115 (Dr. Richard), Evry, France.

Address correspondence and reprint requests to Dr. B. Udd, Department of Neurology, Vaasa Central Hospital, FIN-65130 Vaasa, Finland; e-mail: Bjarne.Udd{at}vshp.fi

Objective: To determine the phenotype variability associated with the specific C-terminal M-line titin mutation known to cause autosomal dominant distal myopathy, tibial muscular dystrophy (TMD; MIM 600334), and limb girdle muscular dystrophy 2J (LGMD2J).

Methods: Three hundred eighty-six individuals were genotyped for the Finnish founder mutation in titin (FINmaj) causing TMD/LGMD2J.

Results: Two hundred seven patients were heterozygous for the mutation. Among these patients, 189 (91%) had a more common phenotype compatible with the classic description of TMD. However, 18 (9%) had unusual phenotypes such as proximal leg or posterior lower leg muscle weakness and atrophy even at onset. Four patients were confirmed homozygotes representing the LGMD2J phenotype. These homozygotes were half of the eight LGMD patients previously described in the original large consanguineous kindred.

Conclusions: Large variability of phenotypic expression caused by just one mutation, the Finnish FINmaj, suggests that no certain phenotype of myopathy/dystrophy can be excluded from being caused by mutated titin. Yet unknown homozygous or compound heterozygous titin mutations without phenotype in the heterozygote carriers may be responsible for undetermined recessive MD and LGMD.




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
A Y Manzur and F Muntoni
Diagnosis and new treatments in muscular dystrophies
Postgrad. Med. J., November 1, 2009; 85(1009): 622 - 630.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Kontrogianni-Konstantopoulos, M. A. Ackermann, A. L. Bowman, S. V. Yap, and R. J. Bloch
Muscle Giants: Molecular Scaffolds in Sarcomerogenesis
Physiol Rev, October 1, 2009; 89(4): 1217 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Lange, K. Ouyang, G. Meyer, L. Cui, H. Cheng, R. L. Lieber, and J. Chen
Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum
J. Cell Sci., August 1, 2009; 122(15): 2640 - 2650.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Y Manzur and F Muntoni
Diagnosis and new treatments in muscular dystrophies
J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 706 - 714.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
I. Kramerova, E. Kudryashova, B. Wu, C. Ottenheijm, H. Granzier, and M. J. Spencer
Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle
Hum. Mol. Genet., November 1, 2008; 17(21): 3271 - 3280.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Fukuzawa, S. Lange, M. Holt, A. Vihola, V. Carmignac, A. Ferreiro, B. Udd, and M. Gautel
Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band - implications for hereditary myopathies
J. Cell Sci., June 1, 2008; 121(11): 1841 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
W. A. Linke
Sense and stretchability: The role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction
Cardiovasc Res, March 1, 2008; 77(4): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Wallgren-Pettersson, V.-L. Lehtokari, H. Kalimo, A. Paetau, E. Nuutinen, P. Hackman, C. Sewry, K. Pelin, and B. Udd
Distal myopathy caused by homozygous missense mutations in the nebulin gene
Brain, June 1, 2007; 130(6): 1465 - 1476.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. C. Olsson, M. Kruger, L.-H. Meyer, L. Ahnlund, L. Gransberg, W. A. Linke, and L. Larsson
Fibre type-specific increase in passive muscle tension in spinal cord-injured subjects with spasticity
J. Physiol., November 15, 2006; 577(1): 339 - 352.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Selcen and K. Bushby
Titinopathies: What happens when a big gene mutates in a big family?
Neurology, February 22, 2005; 64(4): 596 - 597.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.